Maxi Novel
Beijing
About Maxi Novel
Maxi Novel specializes in the fields of oral combination of tumor immunity, targeted drugs, and chemotherapy drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $44.6M
- Funding stage: Late Stage Venture
- Last round: Series C (Oct 2022)
- Website: maxinovel.com
- Phone: +86 021-6100 9600
Industries & Categories
Health Care, Life Science, Medical Device
Canonical: https://fsome.com/organization/maxi-novel-31413 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.